Literature DB >> 8198893

Coronary artery bypass surgery: current practice in the United Kingdom.

M B Izzat1, R R West, A J Bryan, G D Angelini.   

Abstract

OBJECTIVE: To assess current clinical practice in coronary artery bypass surgery and compare it with a previous survey conducted five years ago.
SETTING: United Kingdom.
DESIGN: Postal questionnaires were sent in March 1993 to 120 consultant cardiac surgeons currently performing coronary artery bypass surgery. 104 (87%) were returned by May 1993.
RESULTS: The 104 surgeons who returned the questionnaire performed an estimated total of 25,234 coronary artery bypass operations in 1992 with an average case load per surgeon similar to that in 1987 (243 v 214, NS). The internal mammary artery was regarded as the conduit of choice by 101 surgeons (97%) and was used in 93% of bypass grafts to the left anterior descending coronary artery compared with 73% in 1987 (p < 0.001) but only in 7% of grafts to the circumflex and right coronary systems. There was also a significant increase in the number of surgeons using both internal mammary arteries (88% v 59%, p < 0.01) but only a small increase in those using the internal mammary artery as a sequential graft (55% v 44%, NS). The age of the patient remains one of the main contraindications to the use of the internal mammary artery (40%), together with insufficient mammary flow (42%), endarterectomy (22%), and unstable angina (17%). The right gastroepiploic and inferior epigastric arteries were used only occasionally (3%) when the internal mammary artery or the saphenous vein were not available. Most surgeons (96%) still advocate the use of aspirin to enhance graft patency, with 87% of surgeons continuing treatment indefinitely, compared with 50% in the previous survey (p < 0.001). As for methods of myocardial protection, 72% of surgeons used cardioplegic arrest whereas 28% preferred intermittent aortic cross clamping and fibrillation.
CONCLUSIONS: It is the consensus among British cardiac surgeons that the internal mammary artery is the graft conduit of choice. Its use has been significantly extended over the past five years (1987 to 1992) suggesting a quick response to advancing scientific knowledge. The use of alternative arterial conduits is still limited, perhaps as a reflection of the relative lack of information on their long-term performance. The recently advocated technique of retrograde cardioplegia and continuous warm cardioplegia is not yet popular.

Entities:  

Mesh:

Year:  1994        PMID: 8198893      PMCID: PMC483693          DOI: 10.1136/hrt.71.4.382

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  11 in total

1.  Retrograde continuous warm blood cardioplegia.

Authors:  R M Engelman
Journal:  Ann Thorac Surg       Date:  1991-02       Impact factor: 4.330

Review 2.  The future of saphenous vein as a coronary artery bypass conduit.

Authors:  G D Angelini; A C Newby
Journal:  Eur Heart J       Date:  1989-03       Impact factor: 29.983

3.  Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events.

Authors:  F D Loop; B W Lytle; D M Cosgrove; R W Stewart; M Goormastic; G W Williams; L A Golding; C C Gill; P C Taylor; W C Sheldon
Journal:  N Engl J Med       Date:  1986-01-02       Impact factor: 91.245

4.  Studies of retrograde cardioplegia. II. Advantages of antegrade/retrograde cardioplegia to optimize distribution in jeopardized myocardium.

Authors:  M T Partington; C Acar; G D Buckberg; P L Julia
Journal:  J Thorac Cardiovasc Surg       Date:  1989-04       Impact factor: 5.209

5.  Studies of retrograde cardioplegia. I. Capillary blood flow distribution to myocardium supplied by open and occluded arteries.

Authors:  M T Partington; C Acar; G D Buckberg; P Julia; E R Kofsky; H I Bugyi
Journal:  J Thorac Cardiovasc Surg       Date:  1989-04       Impact factor: 5.209

6.  A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.

Authors:  J H Chesebro; I P Clements; V Fuster; L R Elveback; H C Smith; W T Bardsley; R L Frye; D R Holmes; R E Vlietstra; J R Pluth; R B Wallace; F J Puga; T A Orszulak; J M Piehler; H V Schaff; G K Danielson
Journal:  N Engl J Med       Date:  1982-07-08       Impact factor: 91.245

7.  Coronary artery bypass surgery: current practice in the United Kingdom.

Authors:  G D Angelini; A J Bryan; R R West; A C Newby; I M Breckenridge
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

8.  Does use of gastroepiploic artery graft increase surgical risk?

Authors:  H Suma; Y Wanibuchi; S Furuta; A Takeuchi
Journal:  J Thorac Cardiovasc Surg       Date:  1991-01       Impact factor: 5.209

9.  A new simplified method of optimizing cardioplegic delivery without right heart isolation. Antegrade/retrograde blood cardioplegia.

Authors:  D C Drinkwater; H Laks; G D Buckberg
Journal:  J Thorac Cardiovasc Surg       Date:  1990-07       Impact factor: 5.209

10.  Use of the inferior epigastric artery as a free graft for myocardial revascularization.

Authors:  H B Barner; K S Naunheim; A C Fiore; V W Fischer; H H Harris
Journal:  Ann Thorac Surg       Date:  1991-09       Impact factor: 4.330

View more
  10 in total

1.  Real-world experience of drug-eluting stents in saphenous vein grafts compared to native coronary arteries: results from the prospective multicenter German DES.DE registry.

Authors:  Ibrahim Akin; Marcus Wiemer; Steffen Schneider; Jochen Senges; Matthias Hochadel; Gert Richardt; Mohamed Abdel-Wahab; Karl-Heinz Kuck; Christoph A Nienaber
Journal:  Clin Res Cardiol       Date:  2011-11-13       Impact factor: 5.460

2.  A functional and histopathological comparison of proximal and distal saphenous vein contractility and morphology.

Authors:  Ilhan Golbasi; Arda Tasatargil; Nazif Hikmet Aksoy; Gulay Sadan; Edibe Karasu; Cengiz Turkay; Omer Bayezid
Journal:  Tex Heart Inst J       Date:  2005

3.  Plateletcrit. A platelet marker associated with saphenous vein graft disease.

Authors:  I Akpinar; M R Sayin; Y C Gursoy; T Karabag; E Kucuk; M C Buyukuysal; M Aydin; I C Haznedaroglu
Journal:  Herz       Date:  2013-04-12       Impact factor: 1.443

4.  Antegrade cardioplegia as a possible cause of acute saphenous vein endothelial damage in patients undergoing on pump coronary artery bypass surgery.

Authors:  Ioannis Koukis; Stavros Siminelakis; Michalis Argiriou; Nikolaos Theakos; Anna Takou; George Pounis; Christos Charitos; Efstratios Apostolakis
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

5.  Right Coronary Artery Chronic Total Occlusion After Bypass Grafting Successfully Treated Using Reverse Controlled Antegrade and Retrograde Subintimal Tracking (CART) Technique via the Gastroepiploic Artery: A Case Report.

Authors:  Olivier Van Leuven; Pierre-Jullien Bruyères; Peter Kayaert; Yoann Bataille
Journal:  Am J Case Rep       Date:  2021-04-11

Review 6.  Novel no touch technique of saphenous vein harvesting: Is great graft patency rate provided?

Authors:  Nikolaos A Papakonstantinou; Nikolaos G Baikoussis; John Goudevenos; George Papadopoulos; Efstratios Apostolakis
Journal:  Ann Card Anaesth       Date:  2016 Jul-Sep

Review 7.  Revascularization strategies for patients with established chronic coronary syndrome.

Authors:  Casper F Coerkamp; Marieke Hoogewerf; Bart P van Putte; Yolande Appelman; Pieter A Doevendans
Journal:  Eur J Clin Invest       Date:  2022-04-29       Impact factor: 5.722

Review 8.  Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe?

Authors:  M S Fernández-Alfonso; M Gil-Ortega; I Aranguez; D Souza; M Dreifaldt; B Somoza; M R Dashwood
Journal:  Br J Pharmacol       Date:  2017-03-02       Impact factor: 8.739

9.  Inhibition of neointimal hyperplasia in a rabbit vein graft model following non-viral transfection with human iNOS cDNA.

Authors:  Q-H Meng; S Irvine; A D Tagalakis; R J McAnulty; J R McEwan; S L Hart
Journal:  Gene Ther       Date:  2013-05-02       Impact factor: 5.250

Review 10.  Insights into the pathogenesis of vein graft disease: lessons from intravascular ultrasound.

Authors:  Gavin J Murphy; Gianni D Angelini
Journal:  Cardiovasc Ultrasound       Date:  2004-07-21       Impact factor: 2.062

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.